Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population
- PMID: 17502833
- DOI: 10.1097/01.fpc.0000239975.77088.17
Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population
Abstract
Background and objective: Low nucleotide excision repair (NER) capacity has been associated with increased risk of lung cancer. Excision repair cross-complementing group 1 (ERCC1) is one of the NER core enzymes, and polymorphisms in ERCC1 may lead to altered repair function of the enzyme and therefore confer predisposition to cancer. The goal of this study was to test the hypothesis that common variants in ERCC1 were associated with lung cancer risk.
Methods: The genotyping analyses for 7 selected single nucleotide polymorphisms in ERCC1 using the TaqMan assay was conducted in a case-control study of 1010 patients with incident lung cancer and 1011 cancer-free controls in a Chinese population.
Results: We found that the variant genotypes of the rs3212948 C allele were associated with significantly decreased risk of lung cancer [adjusted odds ratio (OR)=0.73 (95% CI=0.60-0.88) for CG; 0.96 (95% CI=0.65-1.41) for CC and 0.76 (95% CI=0.63-0.91) for CG/CC, compared with the GG genotype]. Similarly, a significant protective effect was also evident for the variant genotypes of rs1007616 C/T [adjusted OR=0.72 (95% CI=0.59-0.89) for CT; 0.90 (95% CI=0.61-1.35) for TT and 0.75 (95% CI=0.62-0.91) for CT/TT, compared with the CC genotype]. Stratified analysis revealed that the protective effects of these 2 single nucleotide polymorphisms were both more evident among young patients and patients without family history of cancer. Consistently, when assessing each unique haplotype compared with the most common haplotype 'TAGCACG', lung cancer risk was significantly decreased among patients who carried the haplotype 'TCCCATT' with the variant rs3212948C and rs1007616T alleles (P value=0.0340, P-sim=0.0325, adjusted OR=0.78; 95% CI=0.63-0.97).
Conclusion: These findings indicate that ERCC1 polymorphisms may contribute to the etiology of lung cancer. Further functional studies were warranted to elucidate the mechanism of the associations.
Similar articles
-
Association studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian population.Cancer Epidemiol. 2011 Apr;35(2):175-81. doi: 10.1016/j.canep.2010.08.007. Epub 2010 Sep 21. Cancer Epidemiol. 2011. PMID: 20863778 Free PMC article.
-
DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population.Int J Cancer. 2005 Jun 20;115(3):478-83. doi: 10.1002/ijc.20911. Int J Cancer. 2005. PMID: 15700316
-
ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females.J Exp Clin Cancer Res. 2009 Dec 14;28(1):153. doi: 10.1186/1756-9966-28-153. J Exp Clin Cancer Res. 2009. PMID: 20003391 Free PMC article.
-
Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.Int J Med Sci. 2007 Feb 1;4(2):59-71. doi: 10.7150/ijms.4.59. Int J Med Sci. 2007. PMID: 17299578 Free PMC article. Review.
-
Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis.Crit Rev Eukaryot Gene Expr. 2017;27(3):267-275. doi: 10.1615/CritRevEukaryotGeneExpr.2017019713. Crit Rev Eukaryot Gene Expr. 2017. PMID: 29199611 Review.
Cited by
-
Genetic determinants for chemo- and radiotherapy resistance in bladder cancer.Transl Androl Urol. 2017 Dec;6(6):1081-1089. doi: 10.21037/tau.2017.08.19. Transl Androl Urol. 2017. PMID: 29354495 Free PMC article. Review.
-
Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.World J Gastroenterol. 2014 Aug 7;20(29):9775-827. doi: 10.3748/wjg.v20.i29.9775. World J Gastroenterol. 2014. PMID: 25110414 Free PMC article. Review.
-
Single Nucleotide Polymorphism Genotyping in Single-Molecule Electronic Circuits.Adv Sci (Weinh). 2017 Jul 26;4(11):1700158. doi: 10.1002/advs.201700158. eCollection 2017 Nov. Adv Sci (Weinh). 2017. PMID: 29201610 Free PMC article.
-
ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer.Pharmgenomics Pers Med. 2011;4:47-63. doi: 10.2147/PGPM.S20317. Epub 2011 Jul 20. Pharmgenomics Pers Med. 2011. PMID: 23226053 Free PMC article.
-
Association studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian population.Cancer Epidemiol. 2011 Apr;35(2):175-81. doi: 10.1016/j.canep.2010.08.007. Epub 2010 Sep 21. Cancer Epidemiol. 2011. PMID: 20863778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical